scholarly article | Q13442814 |
P50 | author | Gianluca De Bellis | Q51932877 |
Ermanno Rizzi | Q56606076 | ||
Arianna Moiani | Q117281724 | ||
Julia Debora Suerth | Q117281725 | ||
Fulvio Mavilio | Q41045259 | ||
Marco Severgnini | Q41108531 | ||
P2093 | author name string | Axel Schambach | |
Francesco Gandolfi | |||
P2860 | cites work | LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes | Q24562936 |
Retroviral DNA integration: ASLV, HIV, and MLV show distinct target site preferences | Q24798872 | ||
Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy | Q28215190 | ||
Hematopoietic stem cell gene transfer in a tumor-prone mouse model uncovers low genotoxicity of lentiviral vector integration | Q28242708 | ||
Hot spots of retroviral integration in human CD34+ hematopoietic cells | Q28302694 | ||
Selection of target sites for mobile DNA integration in the human genome | Q28766367 | ||
Integration targeting by avian sarcoma-leukosis virus and human immunodeficiency virus in the chicken genome | Q28769415 | ||
Transcription start regions in the human genome are favored targets for MLV integration | Q29618456 | ||
HIV-1 integration in the human genome favors active genes and local hotspots | Q29618457 | ||
Retroviral DNA integration: viral and cellular determinants of target-site selection | Q33247467 | ||
Adaptive evolution of conserved noncoding elements in mammals | Q33298406 | ||
Stem-cell gene therapy for the Wiskott-Aldrich syndrome | Q33392766 | ||
Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors | Q33713156 | ||
seqMINER: an integrated ChIP-seq data interpretation platform | Q33777909 | ||
Transposable B2 SINE elements can provide mobile RNA polymerase II promoters | Q73813832 | ||
High-definition mapping of retroviral integration sites defines the fate of allogeneic T cells after donor lymphocyte infusion | Q33784684 | ||
The BET family of proteins targets moloney murine leukemia virus integration near transcription start sites | Q34342339 | ||
Lentiviral hematopoietic stem cell gene therapy in patients with Wiskott-Aldrich syndrome. | Q34356904 | ||
Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy | Q34356914 | ||
Correction of X-linked chronic granulomatous disease by gene therapy, augmented by insertional activation of MDS1-EVI1, PRDM16 or SETBP1. | Q34508425 | ||
Deletion of the LTR enhancer/promoter has no impact on the integration profile of MLV vectors in human hematopoietic progenitors | Q34576925 | ||
Integration profile of retroviral vector in gene therapy treated patients is cell-specific according to gene expression and chromatin conformation of target cell | Q34694796 | ||
Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy | Q35011497 | ||
Whole transcriptome characterization of aberrant splicing events induced by lentiviral vector integrations. | Q35913748 | ||
HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications | Q35914779 | ||
Alpharetroviral self-inactivating vectors: long-term transgene expression in murine hematopoietic cells and low genotoxicity. | Q35939492 | ||
Lentiviral vector integration in the human genome induces alternative splicing and generates aberrant transcripts | Q35944232 | ||
Alpharetroviral vector-mediated gene therapy for X-CGD: functional correction and lack of aberrant splicing | Q36659242 | ||
Reduced genotoxicity of avian sarcoma leukosis virus vectors in rhesus long-term repopulating cells compared to standard murine retrovirus vectors | Q36923886 | ||
BET proteins promote efficient murine leukemia virus integration at transcription start sites | Q37031911 | ||
The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy | Q37143395 | ||
Bromo- and extraterminal domain chromatin regulators serve as cofactors for murine leukemia virus integration | Q37336436 | ||
Mechanisms of retroviral integration and mutagenesis | Q38075040 | ||
Estimated comparative integration hotspots identify different behaviors of retroviral gene transfer vectors | Q38499545 | ||
Self-inactivating alpharetroviral vectors with a split-packaging design | Q39712155 | ||
Genome-scale mapping of DNase I hypersensitivity | Q39842882 | ||
A role for LEDGF/p75 in targeting HIV DNA integration | Q40346940 | ||
Correction of junctional epidermolysis bullosa by transplantation of genetically modified epidermal stem cells. | Q42504368 | ||
Self-inactivating MLV vectors have a reduced genotoxic profile in human epidermal keratinocytes. | Q42820688 | ||
High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. | Q43710599 | ||
Gene therapy for immunodeficiency due to adenosine deaminase deficiency. | Q45882856 | ||
Developmentally regulated activation of a SINE B2 repeat as a domain boundary in organogenesis | Q46172999 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 2 | |
P304 | page(s) | 415-429 | |
P577 | publication date | 2014-05-16 | |
P1433 | published in | Genes | Q5532699 |
P1476 | title | Genome-wide analysis of alpharetroviral integration in human hematopoietic stem/progenitor cells | |
P478 | volume | 5 |
Q38772068 | Alpharetroviral self-inactivating vectors produced by a superinfection-resistant stable packaging cell line allow genetic modification of primary human T lymphocytes |
Q38285765 | Alpharetroviral vectors: from a cancer-causing agent to a useful tool for human gene therapy |
Q92137870 | Enhancing Lentiviral and Alpharetroviral Transduction of Human Hematopoietic Stem Cells for Clinical Application |
Q39214064 | Evolving Gene Therapy in Primary Immunodeficiency |
Q36169656 | HIV-1 Integrates Widely throughout the Genome of the Human Blood Fluke Schistosoma mansoni. |
Q38645986 | HRAS, EGFR, MET, and RON Genes Are Recurrently Activated by Provirus Insertion in Liver Tumors Induced by the Retrovirus Myeloblastosis-Associated Virus 2. |
Q45874795 | Interactions between Retroviruses and the Host Cell Genome. |
Q26795766 | Multifunctional facets of retrovirus integrase |
Q39094431 | Retroviral Vectors for Cancer Gene Therapy |
Search more.